EMERALD ADVISERS, LLC - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 156 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.

Quarter-by-quarter ownership
EMERALD ADVISERS, LLC ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$8,780,000
+15.5%
525,423
-0.3%
0.38%
-13.0%
Q1 2020$7,602,000
-62.7%
527,150
-13.5%
0.44%
-49.0%
Q4 2019$20,401,000
+59.6%
609,523
-0.2%
0.86%
+44.4%
Q3 2019$12,784,000
-26.9%
610,511
-27.4%
0.60%
-15.1%
Q2 2019$17,500,000
-8.2%
840,531
-1.5%
0.70%
-9.4%
Q1 2019$19,064,000
+7.4%
852,991
+15.0%
0.78%
-11.1%
Q4 2018$17,743,000
+33.6%
741,746
+52.4%
0.87%
+78.9%
Q3 2018$13,276,000
+9.6%
486,666
+8.0%
0.49%
+6.8%
Q2 2018$12,112,000
-17.0%
450,436
-1.8%
0.46%
-21.9%
Q1 2018$14,599,000
-17.5%
458,640
-2.0%
0.58%
-14.2%
Q4 2017$17,704,000
+31.8%
468,113
-13.6%
0.68%
+24.7%
Q3 2017$13,437,000
+16.9%
542,035
-3.0%
0.55%
+14.0%
Q2 2017$11,492,000
-9.4%
558,946
-4.2%
0.48%
-7.9%
Q1 2017$12,681,000
-19.8%
583,566
-24.5%
0.52%
-22.7%
Q4 2016$15,808,000
+127.0%
772,995
+66.5%
0.67%
+117.4%
Q3 2016$6,965,000
+138.0%
464,364
+71.7%
0.31%
+119.9%
Q2 2016$2,927,000
-20.1%
270,510
+0.2%
0.14%
-20.8%
Q1 2016$3,662,000
-26.6%
270,060
-0.1%
0.18%
-24.6%
Q4 2015$4,988,000
+378.7%
270,358
+557.2%
0.24%
+337.0%
Q3 2015$1,042,00041,1400.05%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders